What is Preventogen?
Prevent-Plus has just recently launched a groundbreaking technology into the medical and retail segments. Developed by a NASA Polymer Scientist and a world renowned Dermatologist from NYU, this new advanced infection prevention technology is a non-antibiotic, microbicidal liquid polymer that forms a protective film barrier over the skin. The microbicidal agent in the polymer kills microbes (bacteria, fungi and viruses) on contact, and then forms a flexible, organic, odorless and biodegradable barrier that protects the wound from harmful elements, such as water, dirt and germs. This flexible protective barrier also prevents oxygen entering the wound, lowering the pH and creating an optimal healing environment. This polymer contains NO antibiotics, which puts this technology in a whole new class of advanced infection prevention and wound healing. In a recently published prospective, randomized clinical study, the results were outstanding in the reduction of pin site infections in orthopedic trauma applications: – For patient-level analysis, 33.3% of patients in the control group experienced infection, while none of the patients in the PREVENTOGEN group experienced infection (0%) – For pin-level analysis, 23.3% were infected in the control group, while none (0%) were infected in the PREVENTOGEN group – The application of the PREVENTOGEN liquid polymer has shown its effectiveness in dramatically reducing the rate of pin-tract infections related to external fixation procedure With these new data, Prevent Plus is continuing to build evidence of this polymer’s potential as a new class of transformative therapeutic to prevent infection in areas with high un-met clinical need. Prevent Plus currently has two brands in the marketplace: PREVENTOGEN www.preventogen.com and DuraDerm SPORT www.duradermsport.com and are looking to expand their portfolio into animal health, acne treatment and environmental sterilization and decontamination.
Company Leadership
brad chartrand
ceo
Brad Chartrand is the Chief Executive Officer for parent company Prevent Plus and is responsible for Global growth of the Preventogen and DuraDerm SPORT. Mr. Chartrand has over 15 years of Medical Device experience in various Sales and Marketing leadership roles with Applied Medical, CR BARD and AngioDynamics. Prior to Mr. Chartrand’s Medical Device career, he played 8 years of professional hockey, spending five seasons with the Los Angeles Kings (NHL).
joe thomure
Chairman
Joe Thomure is the Chairman and Managing Member of Prevent Plus and stepped out of retirement in 2018 due to his passion and earnest belief in Preventogen. A graduate of the U.S Merchant Marine Academy in Kings Point, New York, Mr. Thomure was called to active duty in the U.S. Navy, during which time he was promoted twice in three years, and eventually received his honorable discharge, pending LCDR in 1977.
Julie Morris
vice president of clinical research and product development
Julie Morris is the Vice President of Clinical Research and Product Development for Preventogen. Her responsibilities include KOL development and clinical studies. Julie has over 19 years of medical device experience including positions with Covidien, Medtronic, Smith & Nephew and various early stage start-ups where she demonstrated success in several commercial roles. Julie works with our KOL team on the advancement of Preventogen’s clinical research and data and has been a key driver for the advancement of infection prevention in wound care.
Involved Industries
Be a Part of the Movement
We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.